156 related articles for article (PubMed ID: 38410602)
21. Intrapleural Thrombolytics as First Line Therapy for Complicated Parapneumonic Effusions and Empyema in Patients with Prohibitive Surgical Risk: A Cases Series.
Morales-Colón S; Rivera-Agosto MM; Mercader-Pérez M; Cantres-Contreras O; Rodríguez-Cintrón W
P R Health Sci J; 2023 Sep; 42(3):241-245. PubMed ID: 37709682
[TBL] [Abstract][Full Text] [Related]
22. Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose.
Popowicz N; Ip H; Lau EPM; Piccolo F; Dootson K; Yeoh C; Phu WY; Brown R; West A; Ahmed L; Lee YCG
Respirology; 2022 Jul; 27(7):510-516. PubMed ID: 35441458
[TBL] [Abstract][Full Text] [Related]
23. Intrapleural Tissue Plasminogen Activator and Dornase Alfa Administration for a Multiloculated Recurrent Malignant Pleural Effusion: A Case Report.
Nikoomanesh K; Phan AT; Sond V; Hasan M
Cureus; 2022 Apr; 14(4):e24373. PubMed ID: 35619869
[TBL] [Abstract][Full Text] [Related]
24. Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection.
Piccolo F; Popowicz N; Wong D; Lee YC
J Thorac Dis; 2015 Jun; 7(6):999-1008. PubMed ID: 26150913
[TBL] [Abstract][Full Text] [Related]
25. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
[TBL] [Abstract][Full Text] [Related]
26. Unintentional intramuscular administration of tPA/DNase for pleural infection.
Popowicz N; Nash M; Lee YC
Respirol Case Rep; 2014 Dec; 2(4):144-6. PubMed ID: 25530865
[TBL] [Abstract][Full Text] [Related]
27. Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection.
Kheir F; Cheng G; Rivera E; Folch A; Folch E; Fernandez-Bussy S; Keyes C; Parikh M; Channick C; Chee A; Majid A
J Bronchology Interv Pulmonol; 2018 Apr; 25(2):125-131. PubMed ID: 29346247
[TBL] [Abstract][Full Text] [Related]
28. Two sequential tPA/DNase courses for noncommunicating loculated collections in pleural infection.
Popowicz N; Piccolo F; Shrestha R; Lee YC
Respirol Case Rep; 2014 Jun; 2(2):87-9. PubMed ID: 25473577
[TBL] [Abstract][Full Text] [Related]
29. A 22-year-old man with pleural tuberculosis associated hydropneumothorax: Case report and literature review.
Sharan LA; Price TP; Hehn B; Manoff D; Cowan SW
Respir Med Case Rep; 2016; 18():27-30. PubMed ID: 27144114
[TBL] [Abstract][Full Text] [Related]
30. Retrospective analysis of large-dose intrapleural alteplase for complicated pediatric parapneumonic effusion and empyema.
Taylor JL; Liu M; Hoff DS
J Pediatr Pharmacol Ther; 2015; 20(2):128-37. PubMed ID: 25964730
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of intrapleural fibrinolytic therapy and dosing strategies used for complicated pleural effusions.
Baumgartner L; Huang E; Sherman D
Pulm Pharmacol Ther; 2022 Oct; 76():102146. PubMed ID: 35868601
[TBL] [Abstract][Full Text] [Related]
32. Intrapleural tissue plasminogen activator for complicated pleural effusions.
Skeete DA; Rutherford EJ; Schlidt SA; Abrams JE; Parker LA; Rich PB
J Trauma; 2004 Dec; 57(6):1178-83. PubMed ID: 15625447
[TBL] [Abstract][Full Text] [Related]
33. Tissue plasminogen activator potently stimulates pleural effusion via a monocyte chemotactic protein-1-dependent mechanism.
Lansley SM; Cheah HM; Varano Della Vergiliana JF; Chakera A; Lee YC
Am J Respir Cell Mol Biol; 2015 Jul; 53(1):105-12. PubMed ID: 25474480
[TBL] [Abstract][Full Text] [Related]
34. Extended Dwell Time Improves Results of Fibrinolytic Therapy for Complex Pleural Effusions.
Patino SH; Tarrazzi F; Tami C; Bellini A; Block M
Cureus; 2020 Aug; 12(8):e9664. PubMed ID: 32923260
[TBL] [Abstract][Full Text] [Related]
35. Intrapleural hemorrhage due to alteplase use in a 6-year-old boy with pleural effusion.
Hendaus MA; Abushahin A
Int J Gen Med; 2013; 6():233-6. PubMed ID: 23626471
[TBL] [Abstract][Full Text] [Related]
36. Intrapleural agents for pleural infection: fibrinolytics and beyond.
Rahman NM
Curr Opin Pulm Med; 2012 Jul; 18(4):326-32. PubMed ID: 22487944
[TBL] [Abstract][Full Text] [Related]
37. Bronchopleural communication following intrapleural doses of tPA/DNase for empyema.
Roy B; Teh MC; Kuok YJ; Lee YCG
Respirol Case Rep; 2020 Oct; 8(7):e00646. PubMed ID: 32884812
[TBL] [Abstract][Full Text] [Related]
38. An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection.
Lau EPM; Eshraghi M; Dootson K; Yeoh C; Ywe Phu W; Lee YCG; Popowicz ND
ERJ Open Res; 2022 Jan; 8(1):. PubMed ID: 35141321
[TBL] [Abstract][Full Text] [Related]
39. Fibrinolytic treatment of complicated pediatric thoracic empyemas with intrapleural streptokinase.
Ekingen G; Güvenç BH; Sözübir S; Tuzlaci A; Senel U
Eur J Cardiothorac Surg; 2004 Sep; 26(3):503-7. PubMed ID: 15302043
[TBL] [Abstract][Full Text] [Related]
40. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions.
Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; McLeay MT
Respir Med; 2012 May; 106(5):716-23. PubMed ID: 22398159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
